A member of the CHIME OTF speaks to a serial health IT entrepreneur to discuss his blueprint for innovation and funding for technology solutions that are addressing the opioid crisis.
Moderator: Art Nicholas
Chief Commercial Officer, Interlace Health and Member, CHIME Opioid Task Force Experienced healthcare software leader, executive at both startups as well as industry leaders such as Nuance Communications.
Guest: David Reeser
Founder and CEO, OpiAID A serial entrepreneur, inventor, and mentor to startup founders. OpiAID is a data science company making the treatment of substance use disorder safer and more effective.
What you’ll learn:
– The process of applying and receiving a SBIR (Small Business Innovation) grant and its impact on one serial entrepreneur’s opioid solution.
– Why a business would want to apply for an SBIR grant and what kind of work it funds.
– Private vs. public sources of funding options and what they might look like for bringing opioid solutions to market.
– What kinds of support and partnerships are necessary for a healthcare IT start-up venture to succeed.
– How the innovation and funding process helped to develop OpiAID, a technology solution created to address the opioid crisis.
– The impact of this solution and how it’s being measured – Mentor advice from a successful entrepreneur to other founders/entrepreneurs.
The CHIME Opioid Task Force (OTF) was launched in early 2018 with a simple mission: to turn the tide on the opioid epidemic using the knowledge and expertise of the nation’s healthcare IT leaders. While our mission is simple, achieving it is not. Opioid addiction is a complex disease that requires long-term, if not lifetime, care from well-informed clinicians who are supported with easy-to-use and reliable tools.